Search

Your search keyword '"Chiarito, Mauro"' showing total 609 results

Search Constraints

Start Over You searched for: Author "Chiarito, Mauro" Remove constraint Author: "Chiarito, Mauro"
609 results on '"Chiarito, Mauro"'

Search Results

103. Corrección en el artículo de Sanz-Sánchez et al., «Tratamiento antiagregante plaquetario único o doble tras implante percutáneo de válvula aórtica. Metanálisis de ensayos clínicos aleatorizados», REC Interv Cardiol. 2021;3:175-181

104. Reversal and removal of oral antithrombotic drugs in patients with active or perceived imminent bleeding.

106. Transcatheter aortic valve replacement in aortic stenosis and cardiac amyloidosis: a systematic review and meta‐analysis

107. Edge‐to‐edge percutaneous mitral repair for functional ischaemic and non‐ischaemic mitral regurgitation: a systematic review and meta‐analysis

108. Percutaneous Tricuspid Valve Repair

109. Prognostic impact of the updated 2018 HFA‐ESC definition of advanced heart failure: results from the HELP‐HF registry

111. Perioperative management of P2Y12 inhibitors in patients undergoing cardiac surgery within 1 year of PCI

112. IMPACT OF CORONARY ARTERY DISEASE ON CLINICAL OUTCOMES AFTER TAVR: INSIGHTS FROM THE BRAVO-3 RANDOMIZED TRIAL

113. PREDICTORS OF ANTIPLATELET CESSATION IN A REAL-WORLD PATIENT POPULATION WITH CORONARY STENTS UNDERGOING NONCARDIAC SURGERY

114. IMPACT OF CHRONIC THROMBOCYTOPENIA ON CLINICAL OUTCOMES AFTER TAVR: INSIGHTS FROM THE BRAVO-3 RANDOMIZED TRIAL

115. Prognostic value of tricuspid regurgitation

116. Correction in article by Sanz-S�nchez et al. �Single or dual antiplatelet therapy after transcatheter aortic valve implantation. A meta-analysis of randomized controlled trials�, REC Interv Cardiol. 2021;3:175-181

117. Correcci�n en el art�culo de Sanz-S�nchez et al., �Tratamiento antiagregante plaquetario �nico o doble tras implante percut�neo de v�lvula a�rtica. Metan�lisis de ensayos cl�nicos aleatorizados�, REC Interv Cardiol. 2021;3:175-181

118. SGLT-2 inhibitors and cardiovascular outcomes in patients with and without a history of heart failure: a systematic review and meta-analysis

119. Evolution of drug-eluting coronary stents: a back-and-forth journey from the bench to bedside.

120. Contributors

123. 21 Direct oral anticoagulants vs. vitamin K antagonists in the treatment of left ventricular thrombosis: a systematic review and meta-analysis

124. 464 Implantation of contemporary transcatheter aortic valves in small aortic annuli: the international multicentre TAVI-SMALL 2 registry

125. 480 Catheter pulmonary vein ablation vs. medical therapy or atrioventricular node ablation and resynchronization in patients with atrial fibrillation and heart failure: a systematic review and meta-analysis

126. 241 Transcatheter aortic valve replacement in aortic stenosis and cardiac amyloidosis: a systematic review and meta-analysis

127. 401 Myocardial viability and ischaemia assessment in chronic coronary total occlusions according to collaterals distribution: a retrospective analysis

129. Abstract 12919: Impact of Small Valve Size After Transcatheter Aortic Valve Implantation on 1-year Outcomes in Women: Results From the WIN-TAVI Registry

130. Abstract 13145: Impact of Chronic Obstructive Pulmonary Disease and Smoking on Clinical Outcomes After Percutaneous Coronary Intervention

131. Abstract 13808: Impact of Complex Percutaneous Coronary Intervention Features Among Patients With or Without Chronic Kidney Disease

132. Tratamiento antiagregante plaquetario �nico o doble tras implante percut�neo de v�lvula a�rtica. Metan�lisis de ensayos cl�nicos aleatorizados

134. TCT-228 Prasugrel or Clopidogrel in Patients With Acute Coronary Syndromes With Multivessel Disease: Results From the PROMETHEUS Study

135. TCT-346 The Mega COMBO Collaboration: An Individual Patient Data Pooled Analysis of Patients Undergoing PCI With COMBO Stent

136. Polymer-free biolimus-A9-eluting stent performance according to renal impairment

137. Efficacy and safety of P2Y12inhibitor monotherapy after complex PCI: a collaborative systematic review and meta-analysis

139. Impact of target vessel choice on outcomes following percutaneous coronary intervention in patients with a prior coronary artery bypass graft

140. Sex-Related Differences in the Prevalence and Prognostic Value of the Academic Research Consortium for High Bleeding Risk Criteria

141. Guided and unguided de-escalation from potent P2Y12 inhibitors among patients with acute coronary syndrome: a meta-analysis

142. Types of myocardial injury and mid-term outcomes in patients with COVID-19

143. Perioperative risk and antiplatelet management in patients undergoing non-cardiac surgery within 1 year of PCI

144. Performance of the academic research consortium high-bleeding risk criteria in patients undergoing PCI for acute myocardial infarction

145. Predictors and Clinical Impact of Prosthesis-Patient Mismatch After Self-Expandable TAVI in Small Annuli - From TAVI FROM TAVI-SMALL Registry

146. Clinical Challenges in an Unusual Setting: ST-Elevation in a Patient Suffering From Graft Versus Host Disease, Between Thrombosis and Coronary Spasm

147. Lopinavir/Ritonavir and Darunavir/Cobicistat in Hospitalized COVID-19 Patients: Findings From the Multicenter Italian CORIST Study

148. Tratamiento antiagregante plaquetario único o doble tras implante percutáneo de válvula aórtica.: Metanálisis de ensayos clínicos aleatorizados

149. Impact of anemia on short-term outcomes after TAVR: A subgroup analysis from the BRAVO-3 randomized trial

Catalog

Books, media, physical & digital resources